Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2019-04-10 | New | $5,029,995 | $5,029,995 | Equity Only | 06b | SEC link |
| 2017-07-13 | New | $2,200,000 | $2,200,000 | Debt Only | 06c | SEC link |
| 2017-04-10 | New | $25,000 | $25,000 | Debt Only | 06c | SEC link |
| 2016-08-12 | Amended | $500,000 | $250,000 | Debt Only | 06b | SEC link |
| 2016-05-27 | New | $250,000 | $250,000 | Debt Only | 06b | SEC link |
| 2016-05-19 | Amended | $705,000 | $440,000 | Debt Only | 06b | SEC link |
| 2016-01-04 | New | $265,000 | $265,000 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Michael G. Bator | Director |
| Daniel L. Cohen | Director, Executive |
| Matthew A. Fitzpatrick | Director |
| Harlan F. Weisman | Director |